title: Use of antiplatelet drugs in stroke prevention: time for a rethink?
authors.forename: Yoon K
authors.initials: YK
authors.lastname: Loke
authors.forename: James R
authors.initials: JR
authors.lastname: White
authors.forename: Joao H
authors.initials: JH
authors.lastname: Bettencourt-Silva
authors.forename: John F
authors.initials: JF
authors.lastname: Potter
authors.forename: Phyo K
authors.initials: PK
authors.lastname: Myint
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011322:Primary Prevention / Q000379:methods*; D055502:Secondary Prevention / Q000379:methods*; D020521:Stroke / Q000188:drug therapy / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000379:methods*; D006113:United Kingdom
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
keywords: Clinical Pharmacology; Stroke Medicine